Comenzo R L
Boston University School of Medicine, USA.
Hosp Pract (1995). 1996 Aug 15;31(8):67-70, 73-4, 79-84 passim. doi: 10.1080/21548331.1996.11443332.
Dose-intensive chemotherapy and marrow transplantation in myeloma achieve complete remission in many cases and may significantly prolong patient survival. Use of myeloid growth factors or mobilized blood stem cell preparations decreases morbidity and mortality from treatment. These approaches also show promise in AL amyloidosis.
大剂量化疗和骨髓移植用于骨髓瘤治疗时,在许多病例中可实现完全缓解,并可能显著延长患者生存期。使用髓系生长因子或动员的造血干细胞制剂可降低治疗相关的发病率和死亡率。这些方法在AL淀粉样变性中也显示出前景。